New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...
AbbVie Inc. closed $6.48 below its 52-week high ($199.95), which the company reached on September 3rd.
That said, investors who do their research can sometimes find durable growth stories that will last for many years to come. Stocks that have strong share price momentum coupled with consistent growth ...